Unknown

Dataset Information

0

Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.


ABSTRACT: Studies in myeloid neoplasms have described recurrent IDH1 and IDH2 mutations as primarily mutually exclusive. Over a 6-month period of clinical testing with a targeted next-generation sequencing assay, we evaluated 92 patients with acute myeloid leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia and identified a subset of 21 patients (23%) who harbored mutations in either IDH1 or IDH2. Of the 21 patients with IDH mutations, 4 (19%) were found to have single nucleotide variants in both IDH1 and IDH2. An additional patient included in the study was found to have two different IDH2 mutations. The mutations were typically present at different variant allelic frequencies, with one predominating over the other, consistent with the presence of multiple subclones in a single patient. In one case, the variant allelic frequencies in both IDH1 and IDH2 were equally low in the setting of a high percentage of blasts, suggesting that the IDH mutations were unlikely to be present in the founding clone. Given these data, we conclude that dual IDH1/2 mutations likely were previously underestimated, a finding that may carry important treatment implications.

SUBMITTER: Platt MY 

PROVIDER: S-EPMC4630164 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Platt Mia Y MY   Fathi Amir T AT   Borger Darrell R DR   Brunner Andrew M AM   Hasserjian Robert P RP   Balaj Leonora L   Lum Amy A   Yip Stephen S   Dias-Santagata Dora D   Zheng Zongli Z   Le Long P LP   Graubert Timothy A TA   Iafrate A John AJ   Nardi Valentina V  

The Journal of molecular diagnostics : JMD 20150830 6


Studies in myeloid neoplasms have described recurrent IDH1 and IDH2 mutations as primarily mutually exclusive. Over a 6-month period of clinical testing with a targeted next-generation sequencing assay, we evaluated 92 patients with acute myeloid leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia and identified a subset of 21 patients (23%) who harbored mutations in either IDH1 or IDH2. Of the 21 patients with IDH mutations, 4 (19%) were found to have single nucleotide varia  ...[more]

Similar Datasets

| S-EPMC8063727 | biostudies-literature
| S-EPMC5548131 | biostudies-other
| S-EPMC5669905 | biostudies-literature
| S-EPMC8175383 | biostudies-literature
| S-EPMC5465954 | biostudies-other
| S-EPMC2923633 | biostudies-literature
| S-EPMC8507987 | biostudies-literature
| S-EPMC10136154 | biostudies-literature
| S-EPMC8171378 | biostudies-literature
| S-EPMC9320300 | biostudies-literature